Comorbidities, Patient Knowledge, and Disease Management in a National Sample of Patients with COPD

被引:166
作者
Barr, R. Graham [1 ,2 ,3 ]
Celli, Bartolome R. [4 ]
Mannino, David M. [5 ]
Petty, Thomas [6 ]
Rennard, Stephen I. [7 ]
Sciurba, Frank C. [8 ]
Stoller, James K. [9 ]
Thomashow, Byron M. [2 ]
Turino, Gerard M. [10 ]
机构
[1] Columbia Univ, Med Ctr, Coll Phys & Surg, Div Gen Med,Dept Med, New York, NY 10032 USA
[2] Columbia Univ, Dept Med, Coll Phys & Surg, Div Pulm Allergy & Crit Care, New York, NY 10032 USA
[3] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA
[4] Tufts Univ, Caritas St Elizabeths Med Ctr, Div Pulm & Crit Care, Boston, MA 02111 USA
[5] Univ Kentucky, Coll Publ Hlth, Dept Prevent Med & Environm Hlth, Lexington, KY 40506 USA
[6] Univ Colorado & Rush Presbyterian St Lukes, Dept Med, Chicago, IL USA
[7] Univ Nebraska Med Ctr, Dept Internal Med, Pulm & Crit Care Med Sect, Omaha, NE USA
[8] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA
[9] Cleveland Clin, Dept Pulm Allergy & Crit Care Med, Cleveland, OH 44106 USA
[10] St Lukes Roosevelt Hosp, James P Mara Ctr, New York, NY 10025 USA
基金
美国国家卫生研究院;
关键词
Asthma; Chronic bronchitis; Chronic obstructive pulmonary disease; Comorbidities; Emphysema; OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; UNITED-STATES; FOLLOW-UP; CARDIOVASCULAR-DISEASE; SYSTEMIC INFLAMMATION; LUNG-FUNCTION; RISK-FACTORS; MORTALITY; HEALTH;
D O I
10.1016/j.amjmed.2008.09.042
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States but is often undertreated. COPD often overlaps with other conditions such as hypertension and osteoporosis, which are less morbid but may be treated more aggressively. We evaluated the prevalence of these comorbid conditions and compared testing, patient knowledge, and management in a national sample of patients with COPD. METHODS: A survey was administered by telephone in 2006 to 1003 patients with COPD to evaluate the prevalence of comorbid conditions, diagnostic testing, knowledge, and management using standardized instruments. The completion rate was 87%. RESULTS: Among 1003 patients with COPD, 61% reported moderate or severe dyspnea and 41% reported a prior hospitalization for COPD. The most prevalent comorbid diagnoses were hypertension (55%), hypercholesterolemia (52%), depression (37%), cataracts (31%), and osteoporosis (28%). Only 10% of respondents knew their forced expiratory volume in 1 second (95% confidence interval [CI], 8-12) compared with 79% who knew their blood pressure (95% CI, 76-83). Seventy-two percent (95% CI, 69-75) reported taking any medication for COPD, usually a short-acting bronchodilator, whereas 87% (95% CI, 84-90) of patients with COPD and hypertension were taking an antihypertensive medication and 72% (95% CI, 68-75) of patients with COPD and hypercholesterolemia were taking a statin. CONCLUSION: Although most patients with COPD in this national sample were symptomatic and many had been hospitalized for COPD, COPD self-knowledge was low and COPD was undertreated compared with generally asymptomatic, less morbid conditions such as hypertension. (C) 2009 Elsevier Inc. All rights reserved. . The American Journal of Medicine (2009) 122, 348-355
引用
收藏
页码:348 / 355
页数:8
相关论文
共 47 条
  • [1] Adams Patricia F, 2006, Vital Health Stat 10, P1
  • [2] Systemic effects of chronic obstructive pulmonary disease
    Agustí, AGN
    Noguera, A
    Sauleda, J
    Sala, E
    Pons, J
    Busquets, X
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (02) : 347 - 360
  • [3] [Anonymous], 2004, N S W Public Health Bull, V15, P107
  • [4] Hospitalizations and mortality in the Lung Health Study
    Anthonisen, NR
    Connett, JE
    Enright, PL
    Manfreda, J
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (03) : 333 - 339
  • [5] EFFECTS OF SMOKING INTERVENTION AND THE USE OF AN INHALED ANTICHOLINERGIC BRONCHODILATOR ON THE RATE OF DECLINE OF FEV(1) - THE LUNG HEALTH STUDY
    ANTHONISEN, NR
    CONNETT, JE
    KILEY, JP
    ALTOSE, MD
    BAILEY, WC
    BUIST, AS
    CONWAY, WA
    ENRIGHT, PL
    KANNER, RE
    OHARA, P
    OWENS, GR
    SCANLON, PD
    TASHKIN, DP
    WISE, RA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (19): : 1497 - 1505
  • [6] Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis
    Barr, R. G.
    Bourbeau, J.
    Camargo, C. A.
    Ram, F. S. F.
    [J]. THORAX, 2006, 61 (10) : 854 - 862
  • [7] Barr R Graham, 2005, Am J Med, V118, P1415
  • [8] Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease
    Bestall, JC
    Paul, EA
    Garrod, R
    Garnham, R
    Jones, PW
    Wedzicha, JA
    [J]. THORAX, 1999, 54 (07) : 581 - 586
  • [9] Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
    Calverley, Peter M. A.
    Anderson, Julie A.
    Celli, Bartolome
    Ferguson, Gary T.
    Jenkins, Christine
    Jones, Paul W.
    Yates, Julie C.
    Vestbo, Jorgen
    Calverley, P. M. A.
    Anderson, J. A.
    Celli, B.
    Ferguson, G. T.
    Jenkins, C.
    Jones, P. W.
    Knobil, K.
    Yates, J. C.
    Vestbo, J.
    Cherniack, R.
    Similowski, T.
    Cleland, J.
    Whitehead, A.
    Wise, R.
    McGarvey, L.
    John, M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) : 775 - 789
  • [10] DEATH CERTIFICATE REPORTING OF CONFIRMED AIRWAYS OBSTRUCTIVE DISEASE
    CAMILLI, AE
    ROBBINS, DR
    LEBOWITZ, MD
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 133 (08) : 795 - 800